You May Also Like
Verily Life Sciences develops tools and devices to collect, organize and activate health data, and creates interventions to prevent and manage disease. The company partners with leading life sciences, medical device and government organizations, using deep hardware, software, scientific, and healthcare expertise to enable faster development, meaningful advances, and deployment at scale.
Remidio is an ophthalmic products company that offers products at affordable prices. The company's vision is to bring to market ophthalmic devices that are affordable, easy-to-use, and built with a larger aim of tackling avoidable blindness in resource-starved situations.
Retinai supports eye care professionals and patients throughout the medical examination process using Artificial Intelligence. Its vision is to foster the transition from reactive medicine to preventive medicine for high-impact diseases such as age-related Macular Degeneration, Diabetic Retinopathy, and Glaucoma. Its solutions rely on advances in medical image analysis, opthalmology, and machine learning.
Skin Analytics is a self-screening service for web and mobile that detects changes in moles. A small change in a mole is a key early warning sign for melanoma. Using a smartphone or digital camera photos can be uploaded to the website or mobile app. Our patent-pending image processing software corrects for differences in angle, lighting and focal length. By comparing mole images over time, our system can alert users to a change in a mole and prompt them to seek help earlier. Early detection is essential in melanoma. An increase in the depth of the cancer of just 1/10th of a millimetre can reduce survival by 30%. Our service makes mole mapping easy, detects subtle changes, and helps users to get in the habit of checking their skin.
Eyenuk is focused on quickly and accurately identifying patients suffering from potentially blinding eye diseases and preserving their vision. Using computer vision and image analysis expertise, the company is developing a portfolio of products based on its proprietary retinal image analysis technology to identify and track the progression of eye diseases including diabetic retinopathy and age-related macular degeneration.
AEYE Health is a digital health company that aims to enable automated, AI-based diagnostic screening solutions for retinal imaging.